After a year-long investigation, the House of Representatives Committee on Ways and Means found “there is a need and desire for professional medical societies to lead the way in a critical reexamination of how race and ethnicity data, when used improperly…can create worse outcomes for patients of color.”
Priority #3: ACCELERATE INNOVATION and expand patient choice. We need to develop future leaders in nephrology who can move the field forward scientifically and serve as advocates for our patients and our specialty.
ASN joined several other health care professional societies in a meeting with the White House Domestic Policy Council and Office of Public Engagement to discuss clinical labor direct cost issues updates (as announced in the proposed CY 2022 Medicare Physician Fee Schedule (MPFS) rule) and its potential impact to patient care.
Embracing early intervention and emphasizing health over end-stage treatment, ASN's initiative, “We’re United 4 Kidney Health,” is both a roadmap and rallying cry of how, together, we can build the bridge to a new world without kidney diseases.
Under a five-year cooperative agreement awarded by the Centers for Disease Control and Prevention to the Council of Medical Specialty Societies, ASN, along with six other member subspeciality societies, will help improve adult immunization rates for high-risk adults.
In a recent letter to the Centers for Medicare & Medicaid Services (CMS), ASN submitted comments on a proposed rule concerning the End-Stage Renal Disease (ESRD) Prospective Payment System, Quality Incentive Program, and End-Stage Renal Disease Treatment Choices (ETC) Model.